-
The Safety of 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid
Time of Update: 2023-05-10
Despite its potential cancer-causing properties, 1H-Pyrrolo[3,2-b]pyridine-3-carboxylic acid is still widely used in the chemical industry, and it is typically handled with care to minimize the risk of exposure.
-
August 23 London Morning Review
Time of Update: 2022-12-03
Overnight, London copper opened at 4809. 5 US dollars / ton, during the Asian session, the US dollar was driven by hawkish remarks to open high and go higher, standing on the 5-day moving average, cru
-
The technology gap of CNPC residue hydrogenation catalyst has been successfully filled
Time of Update: 2022-11-18
PetroChinaResidue oil hydrogenation is the most effective residue oil raw material conversion and treatment technology, catalyst is its core technology, but its high technical content, difficult research and development, application conditions are extremely harsh, is a difficult hard bone, the core technology is only a few international large companies mastered.
-
Recent advances in Staphylococcus aureus bacteremia
Time of Update: 2022-10-21
While the past two years have been dominated by the COVID-19 pandemic, important publications related to the epidemiology and management of SAB have emerged, including new guidelines on methicillin-resistant Staphylococcus aureus (MRSA).
-
Speech training combined with tDCS intervention in the analysis of the efficacy of children with language delay
Time of Update: 2022-10-02
【Research Conclusion】In summary, the traditional therapy combined with tDCS for the treatment of children's language development delay has a good clinical effect, which can significantly improve the child's language ability and oral motor function, improve the development status of the child, and deserve clinical promotion.
-
Invest 10.8 billion
Time of Update: 2022-09-16
On January 3, at the beginning of the new year, the unveiling ceremony of Fujian Nenghua Group Fujian Haiquan Chemical Co. , Ltd. and the commencement ceremony of a series of projects were held in Zha
-
Huahai is up
Time of Update: 2022-09-09
At present, Huahai Pharmaceutical has 15 innovative drugs (12 Class 1 new drugs) Among them, 2 new drugs are in phase III clinical stage and are expected to be marketed; 38 varieties have been reviewed (15 first), and a total of 18 varieties have won bids for national centralized procurement; 26 new categories of reported products are under review, of which 3 No first imitation (including first imitation of dosage form) has been approved yet .
-
National Institutes of Health | ACC Calcium Supplements Beneficial Against Resistance Training Inflammation and Muscle Damage
Time of Update: 2022-09-08
NIH: ACC Calcium Supplements Beneficial Against Resistance Training Inflammation and Muscle Damagefigure 1figure 1 Figure 1 Mean percent change scores ± 95% confidential intervals (CI) for performance valuables.
-
The oil production rate of waste plastic liquefaction to oil technology reaches 80
Time of Update: 2022-08-17
When it reaches 80%, the solid waste residue can be treated harmlessly, and the whole process does not produce dioxins and no secondary pollution, and realizes the technological breakthrough of waste plastic liquid oil production The review meeting of waste plastic liquefaction-to-oil technology organized by China Petroleum and Chemical Industry Federation was held in Tibet Building, Beijing.
-
A new mechanism of parasitic wasp symbiotic virus bidirectional regulation of host immunity
Time of Update: 2022-08-15
CvBV_28-1 inhibits the proliferation of host blood cells and significantly reduces the number of host blood cellsAt the same time, it was also found that CvBV_28-1 relies on Ca 2+ to produce agglutination reaction, has a classic bacterial clearance function against Gram-positive bacteria, and can enhance the immunity of the host when it is infected by bacteria after being parasitized, thereby improving the parasitic wasp larvae.
-
Sci Rep: Scientists hope to use novel epigenetic biomarker to predict infant's risk of preterm birth
Time of Update: 2022-05-23
Recently, in a research report titled "Preterm birth buccal cell epigenetic biomarkers to facilitate preventative medicine" published in the international journal Scientific Reports, scientists from Indiana University and other institutions found in the cheek cells of the parents of premature babies.
-
The plant diversity research team of the Chengdu Institute of Biology has made progress in the chloroplast comparative genomics and palynology research of the genus Sophora genus of the leguminous
Time of Update: 2022-05-21
Since 2018 , the plant diversity research team of Chengdu Institute of Biology, Chinese Academy has extensively collected research materials of Sophora genus, and used Illumina sequencing technology and scanning electron microscopy ( SEM ) to study the chloroplast genome characteristics and sporopollen characteristics of Sophora , respectively.
-
Qilu, Yangzijiang and Kelun are leading the way
Time of Update: 2022-03-03
On January 30, 2022, the "14th Five-Year Plan for the Development of the Pharmaceutical Industry" was released. The data shows that during the "13th Five-Year Plan" period, 964 of 278 varieties pass
-
The establishment of China Southern Rare Earth Group passed the acceptance of the expert group and the establishment was completed
Time of Update: 2022-02-24
On June 27, the acceptance meeting for the establishment of China Southern Rare Earth Group was held in Ganzhou City . The expert group believes that the China Southern Rare Earth Group, jointly fun
-
Yangzi Petrochemical launches safety integrity level assessment
Time of Update: 2022-02-23
By carrying out SIL assessment work, it is possible to prevent under-design or over-design of safety instrumented systems, reduce process risks of production equipment, ensure personal and property safety, protect the environment, and improve the intrinsic safety level of equipment .
